Discount helps NICE flip-flop on Teva's severe asthma contender, Cinqair

20th July 2017 Uncategorised 0

There’s still no word on whether Teva has landed AstraZeneca CEO Pascal Soriot or if he is staying put, as later reports said. But in the meantime, the drugmaker got some good news Thursday on the respiratory front.

More: Discount helps NICE flip-flop on Teva's severe asthma contender, Cinqair
Source: fierce